Elsevier

Public Health

Volume 123, Issue 12, December 2009, Pages 787-788
Public Health

Short Communication
Aspirin for the primary prevention of vascular events?

https://doi.org/10.1016/j.puhe.2009.10.007Get rights and content

Section snippets

Ethical approval

None sought.

Funding

None declared.

Competing interests

None declared.

References (10)

  • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

    Lancet

    (2009)
  • St Elsewhere's NHS Trust

    UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood

    (2007)
  • U. Bulugahapitiya et al.

    Age threshold for vascular prophylaxis by aspirin in patients without diabetes

    Heart

    (2008)
  • N. Sattar et al.

    Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?

    PLoS Med

    (2009)
  • P.M. Rothwell et al.

    Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)

    Lancet

    (2005)
There are more references available in the full text version of this article.

Cited by (0)

View full text